Cloud computing is the game changer for the life sciences industry, according to an article on PharmaBiz.com.
Globally, pharma majors are deploying cloud technology because it provides data security, compliance and transparency, according to Vikram Anand, associate vice president, cloud-based technology & product delivery services, ArisGlobal.
“Cloud is changing the way we deploy technology. Eli Lily uses cloud services for research and development efforts. GSK has chosen to replace its existing Lotus Notes, Domino, and Postini services for its 96,500 employees worldwide, with everything being hosted on the cloud. Roche uses pre-clinical SaaS solution to consolidate several key application areas and harmonize all its sites worldwide,” he said.
The benefits of moving to the cloud computing is the on-demand delivery of IT resources via the Internet with “pay-as-you-go” pricing. It allows enhanced collaboration, lower upfront investment, provides increased return on investment and greater flexibility and faster scale up of operations.
Cloud computing drastically lowers the total cost of ownership, improves collaboration, operational efficiency and speeds up the R&D processes. Security of data on the cloud is better than in-house systems. Data on the cloud is secure and compliant, Anand added.